Selution De-Novo Study Results In-Depth

Monday, March 9, 2026

9:28 AM - 9:36 AM EST

Location: International Ballroom West

Speaker(s)

Christian Spaulding, MD, PhD

Professor of Cardiology
European Hospital Georges Pompidou, Paris, France
Paris, France

Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Terminated, September 30, 2025); CERC: Grant/Research Support (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing); Daiichi Sankyo, Boeringer Ingelheim , Sanofi, AstraZeneca , Chiesi, Bracco, Amgen, Novo Nordisk, Philips: Consulting Fees (e.g., advisory boards) (Terminated, June 30, 2025); French Ministry of Health: Grant/Research Support (Terminated, January 2, 2025); MedAlliance: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated, July 30, 2025); Techwald: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Valcare Medical: Consulting Fees (e.g., advisory boards) (Terminated, September 30, 2025)